{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T22:31:29Z","timestamp":1792276289422,"version":"4.4.0"},"reference-count":80,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>Beta-lactams are the most commonly prescribed antimicrobials in intensive care unit (ICU) settings and remain one of the safest antimicrobials prescribed. However, the misdiagnosis of beta-lactam-related adverse events may alter ICU patient management and impact clinical outcomes. To describe the clinical manifestations, risk factors and beta-lactam-induced neurological and renal adverse effects in the ICU setting, we performed a comprehensive literature review via an electronic search on PubMed up to April 2021 to provide updated clinical data. Beta-lactam neurotoxicity occurs in 10\u201315% of ICU patients and may be responsible for a large panel of clinical manifestations, ranging from confusion, encephalopathy and hallucinations to myoclonus, convulsions and non-convulsive status epilepticus. Renal impairment, underlying brain abnormalities and advanced age have been recognized as the main risk factors for neurotoxicity. In ICU patients, trough concentrations above 22 mg\/L for cefepime, 64 mg\/L for meropenem, 125 mg\/L for flucloxacillin and 360 mg\/L for piperacillin (used without tazobactam) are associated with neurotoxicity in 50% of patients. Even though renal complications (especially severe complications, such as acute interstitial nephritis, renal damage associated with drug induced hemolytic anemia and renal obstruction by crystallization) remain rare, there is compelling evidence of increased nephrotoxicity using well-known nephrotoxic drugs such as vancomycin combined with beta-lactams. Treatment mainly relies on the discontinuation of the offending drug but in the near future, antimicrobial optimal dosing regimens should be defined, not only based on pharmacokinetics\/pharmacodynamic (PK\/PD) targets associated with clinical and microbiological efficacy, but also on PK\/toxicodynamic targets. The use of dosing software may help to achieve these goals.<\/jats:p>","DOI":"10.3390\/microorganisms9071505","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T10:13:42Z","timestamp":1626257622000},"page":"1505","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":129,"title":["Beta-Lactams Toxicity in the Intensive Care Unit: An Underestimated Collateral Damage?"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6055-0034","authenticated-orcid":false,"given":"Claire","family":"Roger","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Pain and Emergency Medicine, N\u00eemes-Caremeau University Hospital, Place du Professeur Robert Debr\u00e9, CEDEX 9, 30029 N\u00eemes, France"},{"name":"UR UM 103 IMAGINE, Faculty of Medicine, Montpellier University, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4096-9356","authenticated-orcid":false,"given":"Benjamin","family":"Louart","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Pain and Emergency Medicine, N\u00eemes-Caremeau University Hospital, Place du Professeur Robert Debr\u00e9, CEDEX 9, 30029 N\u00eemes, France"},{"name":"UR UM 103 IMAGINE, Faculty of Medicine, Montpellier University, 34090 Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s40264-017-0578-2","article-title":"Neurological adverse effects attributable to beta-lactam antibiotics: A literature review","volume":"40","author":"Deshayes","year":"2017","journal-title":"Drug Saf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1517\/14740338.2012.643866","article-title":"Adverse reactions to beta-lactam antimicrobials","volume":"11","author":"Rubinstein","year":"2012","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00134-020-05929-3","article-title":"Antimicrobial-associated harm in critical care: A narrative review","volume":"46","author":"Arulkumaran","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/14740338.2018.1462334","article-title":"An update on adverse drug reactions related to beta-lactam antibiotics","volume":"17","author":"Vardakas","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e0446","DOI":"10.1097\/CCE.0000000000000446","article-title":"Setting the beta-lactam therapeutic range for critically ill patients: Is there a floor or even a ceiling?","volume":"3","author":"Barreto","year":"2021","journal-title":"Crit. Care Explor."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1093\/jac\/dkx209","article-title":"Too much of a good thing: A retrospective study of beta-lactam concentration-toxicity relationships","volume":"72","author":"Imani","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10096-005-0021-y","article-title":"Neurotoxicity induced by beta-lactam antibiotics: From bench to bedside","volume":"24","author":"Chow","year":"2005","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: Management considerations","volume":"72","author":"Grill","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0028-3908(03)00188-6","article-title":"Evidence for the involvement of GABA(A) receptor blockade in convulsions induced by cephalosporins","volume":"45","author":"Sugimoto","year":"2003","journal-title":"Neuropharmacology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S0749-0704(05)70367-5","article-title":"Antibiotic-induced convulsions","volume":"13","author":"Wallace","year":"1997","journal-title":"Crit. Care Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1212\/WNL.21.7.759","article-title":"Penicillinase and the convulsant action of penicillin","volume":"21","author":"Gutnick","year":"1971","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2004.06.004","article-title":"Penicillin blocks human alpha 1 beta 1 and alpha 1 beta 1 gamma 2S GABAA channels that open spontaneously","volume":"496","author":"Lindquist","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1345\/aph.1L307","article-title":"Cephalosporin-induced neurotoxicity: Clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring","volume":"42","author":"Grill","year":"2008","journal-title":"Ann. Pharmacother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"R264","DOI":"10.1186\/cc13094","article-title":"Cefepime neurotoxicity in the intensive care unit: A cause of severe, underappreciated encephalopathy","volume":"17","author":"Fugate","year":"2013","journal-title":"Crit. Care"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.seizure.2020.08.012","article-title":"Antibiotic-induced epileptic seizures: Mechanisms of action and clinical considerations","volume":"81","author":"Wanleenuwat","year":"2020","journal-title":"Seizure"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1192\/bjp.156.4.554","article-title":"Acute psychotic reactions and stress response syndromes following intramuscular aqueous procaine penicillin","volume":"156","author":"Ilechukwu","year":"1990","journal-title":"Br. J. Psychiatry"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"ofx170","DOI":"10.1093\/ofid\/ofx170","article-title":"Characterizing cefepime neurotoxicity: A systematic review","volume":"Volume 4","author":"Appa","year":"2017","journal-title":"Open Forum Infectious Diseases"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13054-017-1856-1","article-title":"Cefepime-induced neurotoxicity: A systematic review","volume":"21","author":"Payne","year":"2017","journal-title":"Crit. Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12028-019-00682-y","article-title":"Clinical, electroencephalographic features and prognostic factors of cefepime-induced neurotoxicity: A retrospective study","volume":"31","author":"Li","year":"2019","journal-title":"Neurocrit. Care"},{"key":"ref_20","first-page":"497","article-title":"Elevated beta-lactam concentrations associated with neurological deterioration in ICU septic patients","volume":"81","author":"Beumier","year":"2015","journal-title":"Minerva Anestesiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/jac\/27.4.405","article-title":"Neurotoxicity of beta-lactam antibiotics: Predisposing factors and pathogenesis","volume":"27","author":"Schliamser","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archsurg.1945.01230030074003","article-title":"Convulsive factor in commercial penicillin","volume":"50","author":"Walker","year":"1945","journal-title":"Arch. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/AAC.39.1.232","article-title":"Relationship between structure and convulsant properties of some beta-lactam antibiotics following intracerebroventricular microinjection in rats","volume":"39","author":"Ammendola","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1212\/WNL.0000000000002023","article-title":"Seizures as adverse events of antibiotic drugs: A systematic review","volume":"85","author":"Sutter","year":"2015","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.cmi.2017.01.005","article-title":"Cefepime plasma concentrations and clinical toxicity: A retrospective cohort study","volume":"23","author":"Huwyler","year":"2017","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00002018-200730080-00002","article-title":"Safety profile of meropenem: An updated review of over 6000 patients treated with meropenem","volume":"30","author":"Linden","year":"2007","journal-title":"Drug Saf."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/jac\/dku111","article-title":"The risk of seizures among the carbapenems: A meta-analysis","volume":"69","author":"Cannon","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/FTD.0b013e318260f7b3","article-title":"Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: Overview of 6 cases","volume":"34","author":"Park","year":"2012","journal-title":"Ther. Drug Monit."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10096-020-04149-3","article-title":"Serious adverse events with novel beta-lactam\/beta-lactamase inhibitor combinations: A large-scale pharmacovigilance analysis","volume":"40","author":"Gatti","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00134-001-1170-9","article-title":"Cefepime-induced neurotoxicity: An underestimated complication of antibiotherapy in patients with acute renal failure","volume":"28","author":"Chatellier","year":"2002","journal-title":"Intensive Care Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/0886022X.2013.794684","article-title":"Antibiotic-induced neurotoxicity in dialysis patients: A retrospective study","volume":"35","author":"Zhang","year":"2013","journal-title":"Ren. Fail."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Quinton, M.C., Bodeau, S., Kontar, L., Zerbib, Y., Maizel, J., Slama, M., Masmoudi, K., Lemaire-Hurtel, A.S., and Bennis, Y. (2017). Neurotoxic concentration of piperacillin during continuous infusion in critically ill patients. Antimicrob. Agents Chemother., 61.","DOI":"10.1128\/AAC.00654-17"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9343(88)90071-X","article-title":"Factors predisposing to seizures in seriously ill infected patients receiving antibiotics: Experience with imipenem\/cilastatin","volume":"84","author":"Calandra","year":"1988","journal-title":"Am. J. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.chest.2020.01.051","article-title":"Effect of cefepime on neurotoxicity development in critically ill adults with renal dysfunction","volume":"158","author":"Khan","year":"2020","journal-title":"Chest"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/clpt.1990.149","article-title":"Pharmacokinetics of cefepime in subjects with renal insufficiency","volume":"48","author":"Barbhaiya","year":"1990","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.clinthera.2014.09.020","article-title":"Neurotoxicity with antimicrobials in the elderly: A review","volume":"36","author":"Mattappalil","year":"2014","journal-title":"Clin. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00134-020-06050-1","article-title":"Antimicrobial therapeutic drug monitoring in critically ill adult patients: A position paper","volume":"46","author":"Alffenaar","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1093\/jac\/dkv165","article-title":"The Working Group for Antimicrobial Use in the ICU within the Infection Section of the European Society of Intensive Care Medicine (ESICM). The ADMIN-ICU survey: A survey on antimicrobial dosing and monitoring in ICUs","volume":"70","author":"Tabah","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/jac\/dkt523","article-title":"An international, multicentre survey of beta-lactam antibiotic therapeutic drug monitoring practice in intensive care units","volume":"69","author":"Wong","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1183\/09031936.00149508","article-title":"Feedback dose alteration significantly affects probability of pathogen eradication in nosocomial pneumonia","volume":"34","author":"Scaglione","year":"2009","journal-title":"Eur. Respir. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s15010-019-01352-z","article-title":"Therapeutic drug monitoring-guided continuous infusion of piperacillin\/tazobactam significantly improves pharmacokinetic target attainment in critically ill patients: A retrospective analysis of four years of clinical experience","volume":"47","author":"Richter","year":"2019","journal-title":"Infection"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Neely, M.N., Kato, L., Youn, G., Kraler, L., Bayard, D., van Guilder, M., Schumitzky, A., Yamada, W., Jones, B., and Minejima, E. (2018). Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic vancomycin dosing. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.02042-17"},{"key":"ref_44","first-page":"957","article-title":"Is high-dose beta-lactam therapy associated with excessive drug toxicity in critically ill patients?","volume":"82","author":"McDonald","year":"2016","journal-title":"Minerva Anestesiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1128\/AAC.01595-08","article-title":"High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function","volume":"54","author":"Lamoth","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13054-019-2378-9","article-title":"Optimization of the treatment with beta-lactam antibiotics in critically ill patients-guidelines from the French Society of Pharmacology and Therapeutics (Societe Francaise de Pharmacologie et Therapeutique-SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Societe Francaise d\u2019Anesthesie et Reanimation-SFAR)","volume":"23","author":"Guilhaumou","year":"2019","journal-title":"Crit. Care"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0272-2712(18)30459-1","article-title":"Assessment of renal function\u2014Glomerular and tubular","volume":"13","author":"Duarte","year":"1993","journal-title":"Clin. Lab. Med."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e000635","DOI":"10.1136\/bmjopen-2011-000635","article-title":"Kidney failure related to broad-spectrum antibiotics in critically ill patients: Secondary end point results from a 1200 patient randomised trial","volume":"2","author":"Jensen","year":"2012","journal-title":"BMJ Open"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.12788\/jhm.2684","article-title":"Acute kidney injury in patients treated with vancomycin and piperacillin-tazobactam: A retrospective cohort analysis","volume":"12","author":"Rutter","year":"2017","journal-title":"J. Hosp. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1053\/j.ajkd.2014.04.027","article-title":"Biopsy-proven acute interstitial nephritis, 1993-2011: A case series","volume":"64","author":"Muriithi","year":"2014","journal-title":"Am. J. Kidney Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.ackd.2016.11.016","article-title":"Medication-induced interstitial nephritis in the 21st century","volume":"24","author":"Nast","year":"2017","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cccn.2004.09.005","article-title":"Drug-induced renal failure: A focus on tubulointerstitial disease","volume":"351","author":"Markowitz","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"381","DOI":"10.5414\/CN108301","article-title":"Diagnosing drug-induced AIN in the hospitalized patient: A challenge for the clinician","volume":"81","author":"Perazella","year":"2014","journal-title":"Clin. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2215\/CJN.07630717","article-title":"Drug-induced acute interstitial nephritis","volume":"12","author":"Moledina","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/ndt\/gfh485","article-title":"Acute interstitial nephritis: Clinical features and response to corticosteroid therapy","volume":"19","author":"Clarkson","year":"2004","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.ki.5002776","article-title":"Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis","volume":"73","author":"Gonzalez","year":"2008","journal-title":"Kidney Int."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1440-1797.2012.01648.x","article-title":"Acute tubulointerstitial nephritis, treatment with steroid and impact on renal outcomes","volume":"17","author":"Raza","year":"2012","journal-title":"Nephrology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21307\/immunohematology-2019-100","article-title":"Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: Some interesting findings since 2007","volume":"30","author":"Garratty","year":"2014","journal-title":"Immunohematology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"44","DOI":"10.21307\/immunohematology-2019-098","article-title":"Drug-induced immune hemolytic anemia: The last 30 years of changes","volume":"30","author":"Arndt","year":"2014","journal-title":"Immunohematology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000440673","article-title":"Variability of findings in drug-induced immune haemolytic anaemia: Experience over 20 years in a single centre","volume":"42","author":"Mayer","year":"2015","journal-title":"Transfus. Med. Hemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/MPH.0000000000000181","article-title":"Ceftriaxone-induced hemolytic anemia: Case report and review of literature","volume":"37","author":"Northrop","year":"2015","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1177\/1060028014548310","article-title":"Ceftriaxone-induced immune hemolytic anemia","volume":"48","author":"Neuman","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e2064","DOI":"10.1038\/cddis.2015.392","article-title":"Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response","volume":"7","author":"Deuel","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_64","first-page":"500","article-title":"The pathophysiology of extracellular hemoglobin associated with enhanced oxidative reactions","volume":"5","author":"Rifkind","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Garratty, G. (2009). Drug-induced immune hemolytic anemia. Hematol. Am. Soc. Hematol. Educ. Program.","DOI":"10.1182\/asheducation-2009.1.73"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/pai.12140","article-title":"Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis","volume":"25","author":"Liu","year":"2014","journal-title":"Pediatr. Allergy Immunol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.24953\/turkjped.2016.02.016","article-title":"Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin","volume":"58","author":"Vehapoglu","year":"2016","journal-title":"Turk. J. Pediatr."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Leicht, H.B., Weinig, E., Mayer, B., Viebahn, J., Geier, A., and Rau, M. (2018). Ceftriaxone-induced hemolytic anemia with severe renal failure: A case report and review of literature. BMC Pharmacol. Toxicol., 19.","DOI":"10.1186\/s40360-018-0257-7"},{"key":"ref_69","first-page":"57","article-title":"Drug-induced renal disorders","volume":"4","author":"Shahrbaf","year":"2015","journal-title":"J. Renal Inj. Prev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2017.10","article-title":"Crystal nephropathies: Mechanisms of crystal-induced kidney injury","volume":"13","author":"Mulay","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbrc.2011.02.053","article-title":"Ceftriaxone crystallization and its potential role in kidney stone formation","volume":"406","author":"Chutipongtanate","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00467-011-2038-z","article-title":"Increased urinary calcium excretion caused by ceftriaxone: Possible association with urolithiasis","volume":"27","author":"Kimata","year":"2012","journal-title":"Pediatr. Nephrol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.ekir.2020.11.040","article-title":"Acute kidney injury after high doses of amoxicillin","volume":"6","author":"Mousseaux","year":"2021","journal-title":"Kidney Int. Rep."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1128\/AAC.00359-16","article-title":"Amoxicillin crystalluria, an emerging complication with an old and well-known antibiotic","volume":"60","author":"Zeller","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Vodovar, D., Thomas, L., Mongardon, N., Lepeule, R., Lebrun-Vignes, B., Biour, M., Netzer, F., Haouache, H., Le Beller, C., and Dhonneur, G. (2018). Dramatic increase of amoxicillin-induced crystal nephropathy found in a cohort study of French pharmacovigilance centers. Antimicrob. Agents Chemother., 62.","DOI":"10.1128\/AAC.01630-17"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/adc.2003.044156","article-title":"Nephrolithiasis associated with ceftriaxone therapy: A prospective study in 51 children","volume":"89","author":"Avci","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"ref_77","first-page":"11","article-title":"Noncontrast multidetector-row computed tomography scanning for detection of radiolucent calculi in acute renal insufficiency caused by bilateral ureteral obstruction of ceftriaxone crystals","volume":"20","author":"Lu","year":"2012","journal-title":"J. X-ray Sci. Technol."},{"key":"ref_78","first-page":"666","article-title":"Systematic review and meta-analysis of acute kidney injury associated with concomitant vancomycin and piperacillin\/tazobactam","volume":"64","author":"Hammond","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Blevins, A.M., Lashinsky, J.N., McCammon, C., Kollef, M., Micek, S., and Juang, P. (2019). Incidence of acute kidney injury in critically ill patients receiving vancomycin with concomitant piperacillin-tazobactam, cefepime, or meropenem. Antimicrob. Agents Chemother., 63.","DOI":"10.1128\/AAC.02658-18"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13054-017-1899-3","article-title":"Co-administration of vancomycin and piperacillin-tazobactam is associated with increased renal dysfunction in adult and pediatric burn patients","volume":"21","author":"Hundeshagen","year":"2017","journal-title":"Crit. Care"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/7\/1505\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:30:30Z","timestamp":1760164230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/7\/1505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,14]]},"references-count":80,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["microorganisms9071505"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms9071505","relation":{},"ISSN":["2076-2607"],"issn-type":[{"value":"2076-2607","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,14]]}}}